NEWS ROOM

Beyond Nano: Why IBAL Technology Redefines Precision Medicine at the Angstrom Scale

May 22, 2025 | Public Relations

In the ever-evolving world of medical science, terms like "nanotechnology" often dominate discussions about cutting-edge innovation. However, a closer look […]

Ion Gel ZCM-25®: A Promising Solution Against Multidrug-Resistant Acinetobacter baumannii

May 16, 2025 | Public Relations

The rise of multidrug-resistant (MDR) pathogens poses a significant threat to global health, with Acinetobacter baumannii standing out due to […]

Ionophore-Based Topical Therapeutics in Wound Healing: Molecular Mechanisms of ION-ZCM1 in Ion Gel ZCM-25®

April 14, 2025 | News Team

Introduction Ionophore-based topical therapeutics are redefining the landscape of advanced wound care. At the forefront of this innovation is Ion Gel […]

Lyme Disease: Efficacy of Ion Gel ZCM-25® in Focus

December 20, 2024 | Public Relations

Lyme disease, caused by the bacterium Borrelia burgdorferi and transmitted through tick bites, remains a significant challenge in modern medicine. […]

Ion Gel ZCM-25®: Rapid Antiviral Shield Against Dengue Type 2

July 2, 2024 | Public Relations

Puerto Vallarta, Jalisco, Mexico – June 21, 2024—Ion Biotechnology México, S.A. de C.V. proudly announces compelling new test results highlighting the […]

Pharmacokinetics Study on Ion Gel ZCM-25® and ION-ZCM1

April 28, 2023 | Public Relations

Ion Gel ZCM-25® in Breakthrough Study on Systemic Absorption and Oxidative Stress Exploring New Drug Delivery Potential Through Injectable and […]

Ion Biotech Group and Ionic Alliance Group Sign a Collaboration Agreement

July 1, 2021 | Public Relations

Grupo Ion Biotech and Ionic Alliance Group Create a Strategic Collaboration for Global Expansion Grupo Ion Biotech, S.A.P.I. de C.V., […]

IBAL Formulations to Support Prevention of Disease

June 19, 2021 | Public Relations

In a world increasingly burdened by chronic illness and microbial threats, the need for innovative, prevention-oriented therapies has never been […]

Ion Gel ZCM-25® Received COFEPRIS Regulatory Approval in Mexico

February 10, 2021 | Public Relations

Ion Gel ZCM-25® has officially received COFEPRIS regulatory approval in Mexico as a Class 2 Medical Device, marking a significant […]

2+ Cations® is a Trademark of Grupo Ion Biotech

August 1, 2020 | Public Relations

2+ Cations®, a Grupo Ion Biotech registered trademark, S.A.P.I. de C.V., has officially been approved by IMPI—Mexico’s Intellectual Property Institute—for […]

Ion Biotechnology® is a Trademark of Grupo Ion Biotech

May 19, 2020 | Public Relations

Ion Biotechnology®, a registered trademark of Grupo Ion Biotech, S.A.P.I. de C.V., represents more than just a brand—it symbolizes a […]

You can go further and faster by helping others succeed.

MEET OUR PARTNERS